Evidence map›Paper›PMID 28239780›Full record

ArticleEuropean journal of nutrition2018

Sesamin extends lifespan through pathways related to dietary restriction in Caenorhabditis elegans.

Yumiko Nakatani, Yukie Yaguchi, Tomomi Komura, Masakazu Nakadai, Kenji Terao, Eriko Kage-Nakadai, Yoshikazu Nishikawa

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Lignans of Sesame (Molecules (Basel, Switzerland) · 2021
    Review
  4. The Review of Anti-aging Mechanism of Polyphenols onFrontiers in bioengineering and biotechnology · 2021
    Review
  5. Article
  6. Article
  7. Review
  8. TOR Signaling inGenetics · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yumiko NakataniGraduate School of Human Life Science, Osaka City University, Sugimoto 3-3-138 Sumiyosi-ku, Osaka, Osaka, 558-8585, Japan.
Yukie YaguchiGraduate School of Human Life Science, Osaka City University, Sugimoto 3-3-138 Sumiyosi-ku, Osaka, Osaka, 558-8585, Japan.
Tomomi KomuraGraduate School of Human Life Science, Osaka City University, Sugimoto 3-3-138 Sumiyosi-ku, Osaka, Osaka, 558-8585, Japan.
Masakazu NakadaiGraduate School of Human Life Science, Osaka City University, Sugimoto 3-3-138 Sumiyosi-ku, Osaka, Osaka, 558-8585, Japan.
Kenji TeraoCycloChem Co., Ltd., Kobe, 650-0047, Japan.
Eriko Kage-NakadaiGraduate School of Human Life Science, Osaka City University, Sugimoto 3-3-138 Sumiyosi-ku, Osaka, Osaka, 558-8585, Japan. nakadai@life.osaka-cu.ac.jp.ORCID http://orcid.org/0000-0001-5068-0460
Yoshikazu NishikawaGraduate School of Human Life Science, Osaka City University, Sugimoto 3-3-138 Sumiyosi-ku, Osaka, Osaka, 558-8585, Japan.
Osaka City University · JP

Funding

Japan Society for the Promotion of Science 15K15133Japan Society for the Promotion of Science 26830049
6 · The paper itself

Abstract

purposeSesamin, a polyphenolic compound found in sesame seeds, has been reported to exert a variety of beneficial health effects. We have previously reported that sesamin increases the lifespan of Caenorhabditis elegans. In this study, we investigated the molecular mechanisms underlying the longevity effect of sesamin in C. elegans.

methodsStarting from three days of age, Caenorhabditis elegans animals were fed a standard diet alone or supplemented with sesamin. A C. elegans genome array was used to perform a comprehensive expression analysis. Genes that showed differential expression were validated using real-time PCR. Mutant or RNAi-treated animals were fed sesamin, and the lifespan was determined to identify the genes involved in the longevity effects of sesamin.

resultsThe microarray analysis revealed that endoplasmic reticulum unfolded protein response-related genes, which have been reported to show decreased expression under conditions of SIR-2.1/Sirtuin 1 (SIRT1) overexpression, were downregulated in animals supplemented with sesamin. Sesamin failed to extend the lifespan of sir-2.1 knockdown animals and of sir-2.1 loss-of-function mutants. Sesamin was also ineffective in bec-1 RNAi-treated animals; bec-1 is a key regulator of autophagy, and is necessary for longevity induced by sir-2.1 overexpression. Furthermore, the heterozygotic mutation of daf-15, which encodes the target of rapamycin (TOR)-binding partner Raptor, abolished lifespan extension by sesamin. Moreover, sesamin did not prolong the lifespan of loss-of-function mutants of aak-2, which encodes the AMP-activated protein kinase (AMPK).

conclusionsSesamin extends the lifespan of C. elegans through several dietary restriction-related signaling pathways, including processes requiring SIRT1, TOR, and AMPK.

Indexed as

Gene Expression Regulation, DevelopmentalAMP-Activated Protein KinasesAnimalsAntioxidantsCaenorhabditis elegansCaenorhabditis elegans ProteinsCaloric RestrictionDietary SupplementsDioxolesFood Additivesgamma-CyclodextrinsGene Expression ProfilingGene Knockdown TechniquesIntrinsically Disordered ProteinsLignansMutationAMP-Activated Protein KinasesAntioxidantsCaenorhabditis elegans ProteinsDioxolesFood Additivesgamma-cyclodextringamma-CyclodextrinsIntrinsically Disordered ProteinsLignanssesaminSIR-2.1 protein, C elegansSirtuinsTOR Serine-Threonine KinasesCaenorhabditis elegansDietary restrictionLifespanSesamin

Identifiers

PMID28239780
OpenAlexW2590240293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.